相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations
Julia U. Holle et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's) Ten-year experience at a single center
Rodrigo Cartin-Ceba et al.
ARTHRITIS AND RHEUMATISM (2012)
Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
Rona M. Smith et al.
ARTHRITIS AND RHEUMATISM (2012)
B-cell depleting agents for ANCA vasculitides: A new therapeutic approach
Jose A. Gomez-Puerta et al.
AUTOIMMUNITY REVIEWS (2012)
Biologic agents in the treatment of granulomatosis with polyangiitis
U. SPECKS
CLEVELAND CLINIC JOURNAL OF MEDICINE (2012)
Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis
Claire Roubaud-Baudron et al.
JOURNAL OF RHEUMATOLOGY (2012)
Genetically Distinct Subsets within ANCA-Associated Vasculitis
Paul A. Lyons et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients
M. Wendt et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Late-Onset Neutropenia Following Rituximab Therapy in Rheumatic Diseases: Association With B Lymphocyte Depletion and Infections
Daniel Tesfa et al.
ARTHRITIS AND RHEUMATISM (2011)
Retreatment with rituximab based on a treatment-to-target approach provides better disease control than treatment as needed in patients with rheumatoid arthritis: a retrospective pooled analysis
Paul Emery et al.
RHEUMATOLOGY (2011)
The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis
Randi Y. Leavitt et al.
ARTHRITIS AND RHEUMATISM (2010)
Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Eugene P. Rhee et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Longterm Safety of Patients Receiving Rituximab in Rheumatoid Arthritis Clinical Trials
Ronald F. van Vollenhoven et al.
JOURNAL OF RHEUMATOLOGY (2010)
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis.
John H. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis.
Rachel B. Jones et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
EULAR recommendations for the management of primary small and medium vessel vasculitis
C. Mukhtyar et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A Multicenter Survey of Rituximab Therapy for Refractory Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Rachel B. Jones et al.
ARTHRITIS AND RHEUMATISM (2009)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis - Comparison of two independent cohorts
Christian Pagnoux et al.
ARTHRITIS AND RHEUMATISM (2008)
EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis
Bernhard Hellmich et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab
P Eriksson
JOURNAL OF INTERNAL MEDICINE (2005)
Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide
A Knight et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Pathogenic roles of B cells in human autoimmunity: Insights from the clinic
F Martin et al.
IMMUNITY (2004)
A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies
D Jayne et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
